ASH 2013: Dr. Neil Kay Discusses More about Cl... - CLL Support

CLL Support

22,367 members38,474 posts

ASH 2013: Dr. Neil Kay Discusses More about Clonal Evolutional and its Implications for Therapy

bkoffman profile image
bkoffmanCLL CURE Hero
0 Replies

In the second part of my interview with Dr. Kay from Mayo that I just posted on my blog ( bkoffman.blogspot.com ), he talks about how a small resistant clone may become predominant and how long duration therapies may contribute to that risk.

It's worth wrapping our heads around because it has implications on how we should handle our disease and what research should be done.

Stay strong

Brian

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .

You may also like...

ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)

In another interview from ASH 2013 that I just posted on my blog http://bkoffman.blogspot.com , Dr....

Dr. Neil Kay: CLL Society Webinar, Just Diagnosed: What Do I Need to Know?

with our CLL. Dr. Kay is a great teacher and the man to ask about green tea extracts. Stay strong....

iwCLL 2013: Dr. Sharman discusses why we feel so lousy, and much more.

go on from there. Please seem my blog: http://bkoffman.blogspot.com Parts 5-7 will follow in...

ASH 2013: INTERVIEW WITH DR. FURMAN RE: IDELALISIB

last blog post ( http://bkoffman.blogspot.com ), I have a short and interesting video interview with

ASH 2016: Dr. Seymour on Combination therapies with venetoclax

combination therapies for CLL. This week I'm posting an interview on our nonprofit’s website...